Logo

American Heart Association

  2
  0


Final ID: Mo4143

Reassessing Thresholds for Pulmonary Hypertension in Healthy and Early Stage Heart Failure - Project Baseline Health Study

Abstract Body (Do not enter title and authors here): Background: There is increasing evidence that current thresholds for diagnosing pulmonary hypertension (PH) may underestimate its prevalence and importance in clinical practice.
Objective: To determine reference values and correlates of right ventricle systolic pressure tricuspid regurgitation (TR) velocity and (RVSP) in the Project Baseline Health Study (PBHS), with a particular focus on diastolic function and preclinical lung and heart diseases.
Methods: In the PBHS, 2,082 participants underwent transthoracic echocardiography. Of these, 1,132 have tricuspid regurgitation (TR) velocity with reliable estimations of peak TR velocity and RVSP. The association between TR velocity and RVSP and common clinical and TTE parameters were assessed using multidimensional network and multivariable-adjusted regression analyses. Analysis included extensive cardiometabolic risk factors, and diastolic and pulmonary function test parameters. We used the Cox proportional hazard model to analyze the relationship between TR velocity and event-free cardiovascular survival.
Results: The mean age of the participants was 51 years, with 56.6% female and 62.6% White. Overall, 33.7% had hypertension; 10.8% had diabetes; and 78% had CAC <100. The 97th quantile TR velocity was 2.6 m/s and the RVSP was 30mmHg (fig 1). While there was a significant increase in TR velocity with age with significant median and upper quantile relationships, the overall nominal change was small. In our study, RVSP was most strongly associated with diastolic parameters (e’ and E/e’) and forced expiratory volume in 1 second (FEV1). In the multivariable-adjusted analysis, age, history of CVD, and e' were independently associated with RVSP after adjustment for traditional risk factors. While TR velocity and RVSP were related to event-free survival on univariable assessment, survival was more closely associated with e’ velocity on multivariable analysis.
Conclusion: In the multiracial deeply phenotyped PBHS study, TR velocity thresholds were consistent with ASE guidelines and recent The World Alliance Societies of Echocardiography (WASE) studies. The RVSP was mainly related to diastolic parameters and FEV1.
  • Alenezi, Fawaz  ( Duke University Health System , Durham , North Carolina , United States )
  • Daubert, Melissa  ( , Durham , North Carolina , United States )
  • Haddad, Francois  ( Stanford University , Palo Alto , California , United States )
  • Celestin, Bettia  ( Stanford Medecine , San Mateo , California , United States )
  • Santana, Everton  ( Stanford University , Menlo Park , California , United States )
  • Bagherzadeh, Shadi  ( Stanford Health Care , Palo Alto , California , United States )
  • Alajmi, Hasan  ( Duke University Health System , Durham , North Carolina , United States )
  • Salerno, Michael  ( Duke University Health System , Durham , North Carolina , United States )
  • Shah, Svati  ( DUKE UNIV MEDICAL CENTER , Hillsborough , North Carolina , United States )
  • Rajagopal, Sudarshan  ( DUKE UNIVERSITY MEDICAL CENTER , Durham , North Carolina , United States )
  • Douglas, Pamela  ( DUKE UNIVERSITY DUMC , Durham , North Carolina , United States )
  • Author Disclosures:
    Fawaz Alenezi: DO NOT have relevant financial relationships | Melissa Daubert: DO NOT have relevant financial relationships | Francois Haddad: No Answer | Bettia Celestin: DO NOT have relevant financial relationships | Everton Santana: DO NOT have relevant financial relationships | shadi bagherzadeh: DO NOT have relevant financial relationships | Hasan Alajmi: No Answer | Michael Salerno: No Answer | Svati Shah: DO NOT have relevant financial relationships | Sudarshan Rajagopal: DO have relevant financial relationships ; Consultant:APIE Therapeutics:Active (exists now) ; Consultant:Visterra:Active (exists now) ; Consultant:United Therapeutics:Active (exists now) ; Consultant:TotalCME:Active (exists now) ; Consultant:Polarean:Active (exists now) ; Consultant:Merck:Active (exists now) ; Consultant:Liquidia:Active (exists now) ; Consultant:Actelion:Active (exists now) ; Consultant:Insmed:Active (exists now) ; Consultant:Gossamer Bio:Active (exists now) ; Consultant:Altavant:Past (completed) | Pamela Douglas: DO have relevant financial relationships ; Speaker:uptodate:Active (exists now) ; Advisor:cleerly:Past (completed) ; Advisor:foresite labs:Active (exists now) ; Research Funding (PI or named investigator):heartflow:Past (completed)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

New Ways to Assess the Pulmonary Vasculature and Right Ventricle

Monday, 11/18/2024 , 01:30PM - 02:30PM

Abstract Poster Session

More abstracts on this topic:
A Case Series of Papillary Fibroelastomas on the Coumadin ridge

Aboukhatwa Omar, Akiki Elias, Kurmann Reto, Larson Kathryn, Keeney Michael, Bois Melanie, Klarich Kyle

Incidence of Worsening Tricuspid Regurgitation Following Implantation of Leadless versus Dual-Chamber Pacemakers

Aldaas Omar, Gil Jesus, Ho Gordon, Birgersdotter-green Ulrika

More abstracts from these authors:
Proteomic biomarkers are associated with high-risk plaque phenotype and adverse events in the PROMISE trial

Karpurapu Anish, Kwee Lydia, De Calvacamp Caroline, Zhao Elizabeth, Nasir Khurram, Foldyna Borek, Douglas Pamela, Shah Svati

Admission and Discharge B-Natriuretic Peptide Profiles Are Predictive of 1-Year Mortality Above Intermountain Risk Score in Heart Failure Phenotypes

Sanchez Pablo, Odonnell Christian, Bagherzadeh Shadi, Celestin Bettia, Santana Everton, Bair Tami, Haddad Francois, Horne Benjamin

You have to be authorized to contact abstract author. Please, Login
Not Available